Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2A1 | Q16548 | 3/20 | 0.50 |
| ▸ | GSTO1 | P78417 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CFTR | P13569 | 1/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9547586 | 0.81 | L3MBTL1 (0.48) | L3MBTL1ALDH1A1CFTRTRPM8SIGMAR1 | |
| SCHEMBL11220240 | 0.78 | RAB9A (0.60) | L3MBTL1ALDH1A1KMT2ACFTRTRPM8 | |
| SCHEMBL11663103 | 0.78 | ALDH1A1 (0.49) | L3MBTL1ALDH1A1KMT2ASIGMAR1MMP9 | |
| SCHEMBL27847921 | 0.77 | TRPM8 (0.64) | BCL2A1GSTO1ALDH1A1TRPM8 | |
| SCHEMBL21337993 | 0.75 | L3MBTL1 (0.49) | L3MBTL1ALDH1A1KMT2ATRPM8SIGMAR1 | |
| SCHEMBL29208602 | 0.75 | BCL2A1 (0.48) | BCL2A1GSTO1TRPM8 | |
| SCHEMBL21392983 | 0.75 | RXRB (0.52) | BCL2A1GSTO1TRPM8 | |
| SCHEMBL2799227 | 0.75 | SIGMAR1 (0.54) | ALDH1A1KMT2ATRPM8SIGMAR1 | |
| SCHEMBL4085244 | 0.74 | SIGMAR1 (0.59) | ALDH1A1KMT2ASIGMAR1 | |
| SCHEMBL31092738 | 0.74 | BCL2A1 (0.47) | BCL2A1GSTO1TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7763268-B2 | Load bearing hydrogel implants | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2010-07-27 | — | — | US | claimed |
| US-20100029789-A1 | Load Bearing Hydrogel Implants | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2010-02-04 | — | — | US | claimed |
| US-12613233-B2 | Threshold-triggered tracer particles | PATENTPOOL INNOVATIONS MANAGEMENT GMBH (DE) | 2026-04-28 | — | — | US | disclosed |
| EP-4394022-B1 | SUBSTRATE COMPRISING A SURFACE COATED WITH AN EPILAME AGENT AND METHOD FOR DEPILATING SUCH A SUBSTRATE | SWATCH GROUP RES & DEV LTD (CH) | 2026-02-18 | — | — | EP | disclosed |
| EP-4394020-B1 | SUBSTRATE COMPRISING A SURFACE COATED WITH AN EPILAME AGENT AND METHOD FOR EPIMERISING SUCH A SUBSTRATE | SWATCH GROUP RES & DEV LTD (CH) | 2025-07-16 | — | — | EP | disclosed |
| US-20240228796-A1 | SUBSTRATE COMPRISING A SURFACE COVERED WITH AN EPILAME AGENT AND METHOD FOR EPILAME-COATING SUCH A SUBSTRATE | THE SWATCH GROUP RESEARCH AND DEVELOPMENT LTD (CH) | 2024-07-11 | — | — | US | disclosed |
| WO-2024141565-A1 | SUBSTRATE COMPRISING A SURFACE COVERED WITH AN EPILAME AGENT AND METHOD FOR COATING SUCH A SUBSTRATE WITH EPILAME | THE SWATCH GROUP RESEARCH AND DEVELOPMENT LTD (CH) | 2024-07-04 | — | — | WO | disclosed |
| EP-4394020-A1 | SUBSTRATE COMPRISING A SURFACE COATED WITH AN EPILAME AGENT AND METHOD FOR EPIMERISING SUCH A SUBSTRATE | The Swatch Group Research and Development Ltd (CH) | 2024-07-03 | — | — | EP | disclosed |
| EP-4394021-A1 | SUBSTRATE COMPRISING A SURFACE COATED WITH AN EPILAME AGENT AND METHOD FOR EPILAMING SUCH A SUBSTRATE | The Swatch Group Research and Development Ltd (CH) | 2024-07-03 | — | — | EP | disclosed |
| EP-3786415-B1 | THRESHOLD-TRIGGERED TRACER PARTICLES | PATENTPOOL INNOVATIONS MAN GMBH (DE) | 2024-07-03 | — | — | EP | disclosed |
| EP-4394022-A1 | SUBSTRATE COMPRISING A SURFACE COATED WITH AN EPILAME AGENT AND METHOD FOR DEPILATING SUCH A SUBSTRATE | The Swatch Group Research and Development Ltd (CH) | 2024-07-03 | — | — | EP | disclosed |
| US-8917018-B2 | Nanomatrix separation of chromophores and uses thereof in luminescent devices | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2014-12-23 | — | — | US | disclosed |
| US-20110215716-A1 | NANOMATRIX SEPARATION OF CHROMOPHORES AND USES THEREOF IN LUMINESCENT DEVICES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2011-09-08 | — | — | US | disclosed |
| US-7763268-B2 | Load bearing hydrogel implants | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2010-07-27 | — | — | US | disclosed |
| US-20100029789-A1 | Load Bearing Hydrogel Implants | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2010-02-04 | — | — | US | disclosed |
| EP-1809284-A4 | NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK & CO INC (US) | 2009-09-09 | — | — | EP | disclosed |
| US-20070299101-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | MERCK SHARP & DOHME CORP. | 2007-12-27 | — | — | US | disclosed |
| CN-101056635-A | Niacin receptor agonists, compositions containing such compounds and methods of treatment | MERCK & CO INC (US) | 2007-10-17 | — | — | CN | disclosed |
| EP-1809284-A2 | NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | Merck & Co., Inc. (US) | 2007-07-25 | — | — | EP | disclosed |
| WO-2006052555-A2 | NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK & CO., INC. (US) | 2006-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299101-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | LDLR, APOB, FFAR1 | BCL2A1 3487/4885GSTO1 1525/4885L3MBTL1 4782/4885 |
| US-12613233-B2 | Threshold-triggered tracer particles | CD63, MYADM, TMEM63A | BCL2A1 2706/4885GSTO1 2356/4885L3MBTL1 1471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.